论文部分内容阅读
Mesenchymal stem cells(MSCs)as a source for regenerative medicine are now the subject of much clinical attention.There are high expectations due to their safety,low tumorigenic risk,and low ethical concerns.MSC therapy has been approved for acute graft-ve